Last $47.76 USD
Change Today -0.58 / -1.20%
Volume 469.8K
FMI On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Pellini M.D., MBA

Chief Executive Officer, President and Director, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Michael J. Pellini, also known as Mike, M.D., MBA has been the Chief Executive Officer and President at Foundation Medicine, Inc. since May 12, 2011. Dr. Pellini has a breadth of experience in life sciences and the clinical diagnostics and laboratory industries. Dr. Pellini served as the President of Clarient, Inc. since April 28, 2008 and as its Chief Operating Officer since October 2007. While at Clarient, he worked with its leadership team to drive critical regulatory ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

Former Director
Member of Executive Committee of the Board of Trustees
Director and Scientific Advisory Board Member
Former President and Chief Operating Officer
Former Director
Chief Executive Officer, President and Director


Drexel University
Boston College
Thomas Jefferson University
Thomas Jefferson University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$403,887

Stock Options*

All Other Compensation$75,850
Exercisable Options165,655
Exercisable Options Value$3,752,291
Unexercisable Options255,252
Unexercisable Options Value$5,080,152
Total Value of Options$8,832,442
Total Number of Options420,907

Total Compensation*

Total Annual Cash Compensation$675,025
Total Short Term Compensation$403,887
Other Long Term Compensation$75,850
Total Calculated Compensation$1,281,351
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $47.76 USD -0.58


William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at